Peripheral Neuropathy

  title={Peripheral Neuropathy},
  author={Comana Cioroiu and Thomas H. Brannagan},
  journal={Current Geriatrics Reports},
Peripheral neuropathy is thought to affect approximately 24 % of the population over age 70 [3]. It is associated with significant disability and sometimes pain, and its management is often challenging for practitioners. Proper identification and diagnosis is essential as several of its etiologies are treatable, and treatment may not only slow progression but also lead to improvement in nerve function. This review will address the appropriate initial evaluation of these patients, including… 

Tables from this paper

Systematic review of the effectiveness of self-initiated interventions to decrease pain and sensory disturbances associated with peripheral neuropathy
A number of self-management strategies that were initiated by patients, including heat, exercise, meditation, and transcutaneous electrical nerve stimulation (TENS) therapy, may reduce self-reported PN symptoms.
Neural microphysiological systems for in vitro modeling of peripheral nervous system disorders
It is proposed that 3D-bioengineered microphysiological nerve tissue can improve in vitro–in vivo extrapolation and expand the capabilities of in vitro PNS disease modeling.
Association of glucose metabolism, physical activity and fitness with peripheral nervous system function in overweight people
Overweight and obese adults should be encouraged to have an active lifestyle, as even a small increase in physical activity might have a positive effect on PNS function.


Approach to peripheral neuropathy and neuronopathy.
  • R. Barohn
  • Medicine, Biology
    Seminars in neurology
  • 1998
Neuropathic disorders encompass those that affect the neuron's cell body or neuropathies, those affecting the peripheral process, or peripheral neuro Pathies, which are broadly subdivided into the myelinopathies and axonopathies.
Intensive evaluation of referred unclassified neuropathies yields improved diagnosis
Analysis of the frequency and type of various sensory symptoms was helpful in distinguishing between acquired and inherited neuropathies.
Clinical Approach to Peripheral Neuropathy: Anatomic Localization and Diagnostic Testing
History and physical examination remain the most useful tools for evaluating peripheral neuropathy and characterization of a neuropathy aids in limiting the differential diagnosis.
Prevalence of monoclonal protein in peripheral neuropathy
All patients with peripheral neuropathy of unknown cause presenting at the authors' institution within 1 year to determine the prevalence of monoclonal serum proteins in this group were surveyed, and 80% of these patients were evaluated, and 10% had a monocolonal serum protein.
The diabetic neuropathies: practical and rational therapy.
The authors summarize the clinical features of the most common diabetic neuropathies, focusing on those for which therapy is available or under active investigation, and potential treatments for DSP.
A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy.
A logistic regression analysis identified environmental toxin exposure and hypertriglyceridaemia, but not glucose intolerance or alcohol overuse as significant risk factors that deserve further investigation as possible causes of CIAP.
Neuropathy and paraproteins: review of a complex association
  • Y. Rajabally
  • Medicine, Biology
    European journal of neurology
  • 2011
The association of monoclonal gammopathy and neuropathy requires the appropriate neurological/haematological investigations for a precise diagnosis and effective treatment.
Prevalence of peripheral neuropathy in the Parsi community of Bombay
The most common neurologic disorder was peripheral neuropathy with 334 cases (2,384 cases/100,000 population), with diabetes the most common non-compressive etiology.
Usefulness of Skin Biopsies in the Evaluation and Management of Patients with Suspected Small Fiber Neuropathy
Compared to patients with normal skin biopsies, patients with confirmed SFN were significantly more likely to have pain and were more than twice as likely to respond to standard neuropathic pain medications.